Table 2 Predictors of symptomatic laboratory-confirmed SARS-COV-2 reinfection, Mexico 2020
From: Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk
RR (95% CI), p | ||||||
|---|---|---|---|---|---|---|
Bivariate analysis | Multiple analysis | |||||
Gender | ||||||
Female | 1.0000 | 1.0000 | ||||
Male | 0.9998 | (0.9993–1.0004) | 0.574 | 1.0004 | (0.9997–1.0009) | 0.256 |
Age group (years) | ||||||
20–49 | 1.0000 | 1.0000 | ||||
50–59 | 0.9987 | (0.9980–0.9995) | 0.001 | 0.9989 | (0.9981–0.9997) | 0.006 |
60–69 | 0.9984 | (0.9973–0.9996) | 0.007 | 0.9984 | (0.9972–0.9996) | 0.009 |
70 + | 0.9983 | (0.9968–0.9999) | 0.039 | 0.9982 | (0.9966–0.9999) | 0.032 |
Occupation | ||||||
Housewife | 1.0000 | 1.0000 | ||||
Healthcare worker | 1.0043 | (1.0032–1.0054) | < 0.001 | 1.0042 | (1.0030–1.0055) | < 0.001 |
Other healthcare-related | 1.0026 | (1.0013–1.0038) | < 0.001 | 1.0025 | (1.0012–1.0039) | < 0.001 |
Student | 0.9994 | (0.9964–1.0025) | 0.721 | 0.9993 | (0.9961–1.0024) | 0.646 |
Other | 1.0006 | (0.9996–1.0015) | 0.227 | 1.0005 | (0.9994–1.0016) | 0.337 |
Disease severity (at primary infection)a | ||||||
Mild-moderate | 1.0000 | 1.0000 | ||||
Severe | 0.9987 | (0.9979–0.9994) | < 0.001 | 0.9989 | (0.9981–0.9997) | 0.007 |
Personal history of: | ||||||
Obesity (BMI 30 or higher) | ||||||
No | 1.0000 | 1.0000 | ||||
Yes | 0.9996 | (0.9988–1.0003) | 0.228 | 0.9997 | (0.9989–1.0004) | 0.360 |
Type 2 diabetes mellitus | ||||||
No | 1.0000 | 1.0000 | ||||
Yes | 0.9993 | (0.9984–1.0001) | 0.082 | 0.9996 | (0.9987–1.0005) | 0.333 |
Immunosuppressionb | ||||||
No | 1.0000 | 1.0000 | ||||
Yes | 1.0040 | (1.0013–1.0066) | 0.003 | 1.0038 | (1.0011–1.0065) | 0.005 |
Chronic kidney disease | ||||||
No | 1.0000 | 1.0000 | ||||
Yes | 1.0038 | (1.0015–1.0061) | 0.001 | 1.0039 | (1.0016–1.0063) | 0.001 |